NuRinse by is a Otc medication manufactured, distributed, or labeled by NuGenTec. Drug facts, warnings, and ingredients follow.
The hand sanitizer is manufactured using only the following United States Pharmacopoeia (USP) grade ingredients in the preparation of the product (percentage in final product formulation) consistent with World Health Organization (WHO) recommendations:
The firm does not add other active or inactive ingredients. Different or additional ingredients may impact the quality and potency of the product.
HOCl solutions are already included in the WHO list of coronavirus-effective biocides, and in the US EPA ‘N’ list of disinfecting agents able to control emerging pathogens like SARS-CoV-2. 37,126 More than ten branded aqueous HOCl formulations have been cleared by the US FDA for topical use in wound management over the last decade. A Class III medical product approval for HOCl has been granted in the EU, and the Japanese Ministry of Health has approved use of HOCl for topical medical applications. The US FDA has approved HOCl for high level disinfection and sterilization of medical instruments, including those for use at critical (i.e., sterile) sites
NURINSE
hand sanitizer hocl aloe and vitamin e gel gel |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
Labeler - NuGenTec (090331927) |
Registrant - NuGenTec (090331927) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
NuGenTec | 090331927 | manufacture(77368-388) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() NURINSE 88895185 not registered Live/Pending |
NuGeneration Technologies, LLC 2020-04-30 |
![]() NURINSE 88861048 not registered Live/Pending |
NuGeneration Technologies, LLC 2020-04-06 |
![]() NURINSE 87418779 5339183 Live/Registered |
NuGeneration Technologies, LLC 2017-04-20 |